Get the Stockscreener App
1.32
5.04%
-0.07
After Hours:
1.31
-0.01
-0.76%
Acumen Pharmaceuticals Inc stock is traded at $1.32, with a volume of 163.74K.
It is down -5.04% in the last 24 hours and up +4.76% over the past month.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
See More
Previous Close:
$1.39
Open:
$1.39
24h Volume:
163.74K
Relative Volume:
0.39
Market Cap:
$79.96M
Revenue:
-
Net Income/Loss:
$-64.86M
P/E Ratio:
-1.1786
EPS:
-1.12
Net Cash Flow:
$-55.66M
1W Performance:
-8.33%
1M Performance:
+4.76%
6M Performance:
+3.13%
1Y Performance:
-46.12%
1-Day Range:
$1.30
$1.39
1-Week Range:
$1.30
$1.47
52-Week Range:
$0.8551
$3.36
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
Name
Acumen Pharmaceuticals Inc
Sector
Industry
Phone
617-344-4190
Address
1210-1220 WASHINGTON STREET, NEWTON
Compare ABOS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals Inc
|
1.32 | 81.77M | 0 | -64.86M | -55.66M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-17-25 | Initiated | Citigroup | Buy |
| Jul-26-24 | Initiated | Citigroup | Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Jul-20-23 | Resumed | BofA Securities | Buy |
| May-18-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-15-22 | Initiated | BTIG Research | Buy |
| Jun-30-22 | Initiated | H.C. Wainwright | Buy |
| Jan-21-22 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-26-21 | Initiated | BofA Securities | Neutral |
| Jul-26-21 | Initiated | Credit Suisse | Outperform |
| Jul-26-21 | Initiated | Stifel | Buy |
| Jul-26-21 | Initiated | UBS | Buy |
View All
Acumen Pharmaceuticals Inc Stock (ABOS) Latest News
Acumen Pharmaceuticals’ Earnings Call Highlights Strategic Growth - MSN
Is Acumen Pharmaceuticals Inc. still worth holding after the dipEarnings Growth Summary & Weekly Market Pulse Updates - Newser
Combining machine learning predictions for Acumen Pharmaceuticals Inc.Weekly Earnings Recap & Safe Entry Point Identification - Newser
Predicting Acumen Pharmaceuticals Inc. trend using moving averagesInsider Selling & AI Powered Market Trend Analysis - Newser
What recovery options are there for Acumen Pharmaceuticals Inc.July 2025 Momentum & Accurate Entry and Exit Point Alerts - Newser
Will Acumen Pharmaceuticals Inc. bounce back from current supportBull Run & Weekly High Momentum Picks - Newser
What earnings revisions data tells us about Acumen Pharmaceuticals Inc.Earnings Summary Report & Breakout Confirmation Trade Signals - Newser
Live market analysis of Acumen Pharmaceuticals Inc.2025 Performance Recap & Technical Pattern Based Signals - Newser
Risk vs reward if holding onto Acumen Pharmaceuticals Inc.2025 Fundamental Recap & Daily Volume Surge Trade Alerts - Newser
Using flow based indicators on Acumen Pharmaceuticals Inc.Trade Signal Summary & Growth Oriented Trading Recommendations - Newser
Technical signs of recovery in Acumen Pharmaceuticals Inc.July 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - Newser
Building trade automation scripts for Acumen Pharmaceuticals Inc.Portfolio Gains Report & High Win Rate Trade Alerts - Newser
Can you recover from losses in Acumen Pharmaceuticals Inc.2025 Sector Review & Consistent Profit Trading Strategies - Newser
Leading vs lagging indicators on Acumen Pharmaceuticals Inc. performance2025 Biggest Moves & Short-Term Trading Opportunity Alerts - Newser
Will Acumen Pharmaceuticals Inc. price bounce be sustainableJuly 2025 EndofMonth & Daily Profit Focused Screening - Newser
Should you wait for a breakout in Acumen Pharmaceuticals Inc.Earnings Risk Summary & Reliable Price Breakout Signals - Newser
Can machine learning forecast Acumen Pharmaceuticals Inc. recovery2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser
What MACD signals say about Acumen Pharmaceuticals Inc.Trade Analysis Report & AI Powered Buy/Sell Recommendations - Newser
Multi factor analysis applied to Acumen Pharmaceuticals Inc2025 Top Gainers & Safe Entry Momentum Tips - Newser
Can a trend reversal in Acumen Pharmaceuticals Inc. lead to recoveryJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - Newser
What institutional flow reveals about Acumen Pharmaceuticals Inc.New Guidance & Safe Entry Momentum Tips - Newser
Is Acumen Pharmaceuticals Inc. stock ready for a breakoutWeekly Trade Recap & Daily Profit Maximizing Tips - Newser
Technical analysis overview for Acumen Pharmaceuticals Inc. stockJuly 2025 Sector Moves & Growth Focused Entry Reports - Newser
Can Acumen Pharmaceuticals Inc. recover in the next quarterJuly 2025 Selloffs & Free Community Consensus Stock Picks - Newser
Tick level data insight on Acumen Pharmaceuticals Inc. volatilityMarket Movers & Daily Volume Surge Trade Alerts - Newser
Published on: 2025-09-09 05:33:01 - Newser
Is Acumen Pharmaceuticals Inc. stock entering bullish territoryRecession Risk & Fast Entry Momentum Trade Alerts - Newser
Acumen Pharmaceuticals Inc Stock (ABOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):